X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BLRX

Closed

Biolinerx Ltd

4.53
-0.04 (-0.88%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.57
Day's Range: 4.4099 - 4.57
Send
When Written:
 
0.8865
BioLineRx Ltd is a clinical-stage biopharmaceutical company focused on developing novel therapies for oncology, immunology, and cardiovascular diseases. The company was founded in 2003 and is headquartered in Modi'in, Israel.

BioLineRx's pipeline includes a range of therapeutic candidates in various stages of development, including BL-8040 for the treatment of multiple cancer indications, BL-5010 for the non-surgical removal of skin lesions, and BL-1210 for the treatment of chronic hepatitis C virus infection.

The company has collaborations with various pharmaceutical companies, academic institutions, and government agencies, including Novartis, Merck, and the National Institutes of Health.

BioLineRx has a global presence, with operations in Israel, the United States, and Europe. The company is listed on the NASDAQ and the Tel Aviv Stock Exchange.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X